CDH16 and papillary carcinoma: Considering the unequivocal and strong CDH16 staining in all normal thyroid samples, as well as the CDH16 expression loss in more than 90% of our papillary carcinomas, CDH16 loss appears to constitute a strong argument in favor of a papillary carcinoma.